Clinical Trial Update: Stem Cell Migratory Activity: Prognostic Marker in Myocardial Ischemia

View source ↗

Summary

This completed clinical trial update reports findings on stem cell migratory activity as a prognostic marker in myocardial infarction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Snippet

Sponsor: IRCCS Multimedica | Conditions: Myocardial Infarction | Status: COMPLETED